Trichlormethine

Trichlormethine

SCHEMBL338967

Cl.ClCCN(CCCl)CCCl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Trichlormethine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 1.00
TSHR P16473 2/20 0.50
TP53 P04637 1/20 0.50
HTT P42858 1/20 0.50
HBB P68871 1/20 0.50
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 3/20 0.33
BLM P54132 1/20 0.32
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trichlormethine SCHEMBL8224 0.95 LMNA (0.91) LMNATSHRTP53HTTHBB
Trichlormethine SCHEMBL1820371 0.91 LMNA (0.83) LMNATSHRTP53HTTHBB
Trichlormethine SCHEMBL1651598 0.87 LMNA (0.77) LMNATSHRTP53HTTHBB
SCHEMBL12552521 0.84 LMNA (0.71) LMNATSHRTP53HTTHBB
Hydrochloric Acid SCHEMBL31671050 0.83 LMNA (0.69) LMNATSHRTP53HTTHBB
Hydrochloric Acid SCHEMBL27869643 0.83 LMNA (0.69) LMNATSHRTP53HTTHBB
Hydrochloric Acid SCHEMBL6780518 0.83 LMNA (0.69) LMNATSHRTP53HTTHBB
Hydrochloric Acid SCHEMBL2771613 0.83 LMNA (0.69) LMNATSHRTP53HTTHBB
SCHEMBL7039551 0.81 LMNA (0.67) LMNATSHRTP53HTTHBB
SCHEMBL12552525 0.81 LMNA (0.67) LMNATSHRTP53HTTHBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119790166-A Markers for early detection of colonic cell proliferative disorders 福瑞诺姆控股公司 2025-04-08 CN claimed
CN-112855120-B Automatic metering device for single well and two phases of oil field 陕西延长石油(集团)有限责任公司 2025-03-18 CN claimed
CN-110057302-B Underground safety-oriented full-automatic measuring device and measuring method 南京工业职业技术学院 2024-08-27 CN claimed
CN-117384232-A Primer synthesis method with high ammonolysis degree 通用生物(安徽)股份有限公司 2024-01-12 CN claimed
CN-115710429-A Hydrolysis-resistant alcoholysis-resistant reinforced nylon material and preparation method thereof 青岛国恩科技股份有限公司 2023-02-24 CN claimed
CN-113477052-B Aminoethylated piperazine, preparation method thereof, carbon dioxide absorbent and application thereof 大连理工大学 2022-05-24 CN claimed
CN-109516919-B Preparation method of tri (2-aminoethyl) amine 安徽工业大学科技园有限公司 2021-12-14 CN claimed
CN-109438252-B Synthesis process of tri (2-aminoethyl) amine 安徽工业大学科技园有限公司 2021-12-14 CN claimed
CN-113477052-A Aminoethylated piperazine, preparation method thereof, carbon dioxide absorbent and application thereof 大连理工大学 2021-10-08 CN claimed
CN-108164428-B Preparation method of tris (2-chloroethyl) amine hydrochloride 山东泰和水处理科技股份有限公司 2021-06-18 CN claimed
US-20200131431-A1 CHEMICAL ADDITIVES AND SURFACTANT COMBINATIONS FOR FAVORABLE WETTABILITY ALTERATION AND IMPROVED HYDROCARBON RECOVERY FACTORS ALCHEMY SCIENCES INC (US) 2020-04-30 US claimed
US-20190169342-A1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. 2019-06-06 US claimed
US-20140044671-A1 AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS GENZYME CORPORATION (US) 2014-02-13 US claimed
EP-2538947-A1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS Relypsa, Inc. (US) 2013-01-02 EP claimed
WO-2011106545-A1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS RELYPSA, INC. (US) 2011-09-01 WO claimed
US-20100254935-A1 Amine condensation polymers as phosphate sequestrants GENZYME CORPORATION (US) 2010-10-07 US claimed
US-20080085259-A1 Amine condensation polymers as phosphate sequestrants GENZYME CORPORATION 2008-04-10 US claimed
EP-0005094-B1 PROCESS FOR THE PREPARATION OF TRIS-(POLYOXAALKYL)-AMINES RHONE-POULENC INDUSTRIES (FR) 1980-10-29 EP claimed
EP-0005090-B1 PROCESS FOR THE PREPARATION OF TRIS(8-HYDROXY-3,6-DIOXA-OCTYL)-AMINE, AND THE COMPOUND OBTAINED BY THIS PROCESS RHONE-POULENC INDUSTRIES (FR) 1980-10-01 EP claimed
EP-0002147-B1 PROCESS FOR THE PREPARATION OF TRIS(3-OXA-5-HYDROXY-PENTYL)AMINE RHONE-POULENC INDUSTRIES (FR) 1980-07-23 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140044671-A1 AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS PHPT1, CEPT1, PNMT LMNA 3373/4885TSHR 3850/4885TP53 2727/4885
US-20080085259-A1 Amine condensation polymers as phosphate sequestrants PHPT1, CEPT1, PNMT LMNA 3373/4885TSHR 3850/4885TP53 2727/4885
US-20100254935-A1 Amine condensation polymers as phosphate sequestrants PHPT1, CEPT1, PNMT LMNA 3373/4885TSHR 3850/4885TP53 2727/4885
US-20190169342-A1 POLYIMIDAZOLES FOR USE AS BILE ACID SEQUESTRANTS NR1H4, SLC10A2, ITCH LMNA 4519/4885TSHR 3816/4885TP53 4319/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.